Suman Mukhopadhyay, Ph.D.
About Suman Mukhopadhyay, Ph.D.
Suman Mukhopadhyay, Ph.D., is a Postdoctoral Researcher at NYU Langone Health specializing in cancer biology and metabolism. He has extensive experience in signal transduction research and has previously worked at several prestigious institutions including the National Cancer Institute and Weill Cornell Medicine.
Current Position at NYU Langone Health
Suman Mukhopadhyay, Ph.D., has been working as a Postdoctoral Researcher at NYU Langone Health since January 2021. His research focuses on signal transduction within cancer biology and metabolism. He is actively contributing to the field by exploring the molecular mechanisms underlying these processes within the New York City Metropolitan Area.
Previous Experience at National Cancer Institute
From 2016 to 2020, Suman Mukhopadhyay served as a Postdoctoral Research Fellow at the National Cancer Institute (NCI) in Frederick, MD. During his four-year tenure, he conducted significant research which contributed to the understanding of cancer biology. Simultaneously, he held a similar position at the Frederick National Laboratory for Cancer Research.
Academic Roles at Hunter College
Suman Mukhopadhyay held multiple academic positions at Hunter College in the Greater New York City Area. He worked as an Adjunct Assistant Professor for two months in 2015, and as an Adjunct Lecturer from 2010 to 2015. Throughout these roles, he shared his extensive knowledge in biological sciences with students, contributing to the academic environment of the institution.
Doctoral Studies at The Graduate Center, CUNY
Suman Mukhopadhyay pursued his Doctor of Philosophy (Ph.D.) in Cancer Biology/Molecular, Cellular, Developmental Biology at The Graduate Center, City University of New York (CUNY), completing his degree in 2015. This was followed by a Master of Philosophy (M.Phil.) in Cell Biology, Biochemistry/Biological Sciences from 2010 to 2012. His education laid a strong foundation for his specialized research career.
Research Contributions on SHP2/RAS Biology
At the Perlmutter Cancer Center, Suman Mukhopadhyay conducted research under the guidance of Dr. Benjamin G Neel, focusing on SHP2/RAS Biology. His work in this domain has furthered the understanding of molecular pathways and their roles in cancer, which is critical in developing targeted cancer therapies.